Facilitated By

San Antonio Medical Foundation

4E Therapeutics Custom Synthesis and Medicinal Chemistry. Part A MNK

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)
McHardy, Stanton
Funded by
4E Therapeutics, Inc.
Research Start Date
Status
Inactive

Basic Research

Collaborative Project
Basic Research
Drug Discovery
Neuroscience